GRM5 and Huntington disease: Additionally, we recently characterized the longitudinal changes of mGluR5 density occurring during disease progression in the Q175 mouse model of HD [16] by means of positron emission tomography (PET) and found that mGluR5 levels were decreased in HD mice [17].